NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025

NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025

Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera

  • NeoLINK Login
  • Investors
Search
LogoNeoLINK Login
Menu
  • Home
  • Providers
    Providers
    • Oncology solutions
      • Lung cancer
      • Breast cancer
      • Colorectal cancer
      • Gastric cancer
      • Hematologic cancers
    • Pathology solutions
      • Test search
      • Lab services
    • Client support & resources
      • Certifications & licenses
      • Test requisition forms
  • Partners
    Partners
    • Biopharma services
    • Oncology data solutions
    • Regulatory support
  • Patients
  • About NeoGenomics
    About NeoGenomics
    • Who we are
    • Scientific contributions
    • Careers
    • Privacy
    • Contact us
  • Billing
    Billing
    • For clinicians
    • For patients
    • Financial assistance
    • Pay your bill online
  • Test Search
  • Investors
Test Search
Skip to main content Skip to section navigation Skip to footer
NeoGenomics, Inc. IR Overview
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

Press Releases

Investors News & Events Press Releases
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts
Nov 8, 2024 7:00 am EST
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 5, 2024 7:00 am EST
NeoGenomics Reports Third Quarter 2024 Results
Oct 22, 2024 8:10 am EDT
NeoGenomics Receives New York State Approval for Neo Comprehensiveā„¢ Solid Tumor Test
Oct 15, 2024 7:30 am EDT
NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
Oct 8, 2024 8:10 am EDT
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
Sep 23, 2024 6:47 pm EDT
NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
Sep 11, 2024 8:05 am EDT
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Aug 29, 2024 8:05 am EDT
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Jul 29, 2024 4:05 pm EDT
NeoGenomics Reports Second Quarter 2024 Results
Jul 9, 2024 7:00 am EDT
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 NeoGenomics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences